COVID-19 Risk Factors and Multisystem Inflammatory Syndrome Quiz

What did the speaker mention about the data on COVID-19?

According to the speaker, what varies widely around the world?

What did the speaker mention about the Acute Respiratory Clinic (ARC) at Emory TravelWell Center?

What disclaimer did the speaker provide about the guidance for outpatients with COVID-19?

Where can one find the US approach to management of COVID-19 based on evidence-based guidelines?

What did the speaker mention about post-COVID conditions?

What is the reported mortality rate for children diagnosed with Multisystem Inflammatory Syndrome (MIS-C) after COVID-19 infection?

Which factor is NOT listed as a risk factor for severe disease after COVID-19 infection?

What is the key focus of monoclonal therapy in the treatment of COVID-19?

Which syndrome is characterized by severe hyperinflammatory symptoms 2-6 weeks after acute COVID-19 infection?

What percentage of ambulatory young adults (16-30 yrs old) experienced persistent symptoms at 6 months after mild COVID-19 infection?

Which medication has been associated with reducing the risk of severe illness (hospitalization) by 70-80% in COVID-19 patients?

What is the main purpose of Tocilizumab in the treatment of later-stage COVID-19 infection?

What is the presumed efficacy of Sotrovimab against hospitalization or death in non-hospitalized patients with mild to moderate COVID-19?

Which demographic group is NOT associated with an increased risk of Post-Acute Sequelae of SARS-CoV-2 infection (PASC)?

What is the main purpose of Evolving paradigms in the treatment of early COVID-19 infection?

What percentage of participants reported symptoms lasting at least 2 months after seropositive for COVID-19 according to the Sheehan Disability Scale?

Which factor is NOT a possible mechanism for increased incidence of new diabetes diagnoses after COVID-19 infection?

What is the most common initial presentation of COVID-19?

What is the median incubation period for COVID-19?

What are the common symptoms reported in the USS Theodore Roosevelt COVID-19 outbreak?

What did the human challenge study involving intranasal inoculation with pre-alpha wild type virus find as a common symptom?

In which clinical stage of illness does evidence of lower respiratory infection (LRI) appear?

What is one of the inflammatory complications associated with severe or critical COVID-19?

What is a potential reason for the lower rates of severe illness from Omicron?

Which factor is considered protective against severe illness in vaccinated persons with COVID-19?

Which group reported an attack rate of 74% from the Omicron variant outbreak?

What was a common symptom reported in the Norway Christmas party outbreak associated with the Omicron variant?

What are some of the dermatologic findings reported as potential symptoms of COVID-19?

Which medication has been granted EUA for post-exposure prophylaxis of high-risk individuals who are not fully vaccinated or not expected to mount an adequate response to the vaccine?

Which medication is a long-acting mAb that may provide protection for 6 or more months?

Which medication is indicated for pre-exposure prophylaxis for ages ≥12 who are uninfected, without known recent exposure, and have moderate to severe immune compromise and may not mount an adequate response to vaccination?

Which oral antiviral medication is recommended for use in mild-moderate COVID in persons aged ≥12 with risk factors for severe disease within 5 days of symptom onset and decreases the risk of hospitalizations or death by 88%?

Which oral antiviral medication is not recommended in severe renal or hepatic impairment, and has many drug-drug interactions (DDIs)?

Which oral antiviral medication has the potential to decrease the risk of hospitalization or death by 30% in adults with risk factors for severe disease within 5 days of symptom onset when there are no other treatment options?

Which medication's EUA was revoked due to Omicron resistance?